Global Coagulation/Hemostasis Analyzers Industry

Global Coagulation/Hemostasis Analyzers Industry

  • April 2021 •
  • 278 pages •
  • Report ID: 5956350 •
  • Format: PDF
Abstract:
- Global Coagulation/Hemostasis Analyzers Market to Reach $7 Billion by 2027
- Amid the COVID-19 crisis, the global market for Coagulation/Hemostasis Analyzers estimated at US$3.9 Billion in the year 2020, is projected to reach a revised size of US$7 Billion by 2027, growing at aCAGR of 8.7% over the period 2020-2027. Clinical Laboratory Analyzers, one of the segments analyzed in the report, is projected to record 8.4% CAGR and reach US$5.5 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Point-of-Care Testing Analyzers segment is readjusted to a revised 10.3% CAGR for the next 7-year period.
- The U.S. Market is Estimated at $1.1 Billion, While China is Forecast to Grow at 11.8% CAGR
- The Coagulation/Hemostasis Analyzers market in the U.S. is estimated at US$1.1 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.4 Billion by the year 2027 trailing a CAGR of 11.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.9% and 7.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 6.8% CAGR.

- Select Competitors (Total 41 Featured) -
  • Alere, Inc.
  • Diagnostica Stago SAS
  • Helena Laboratories, Inc.
  • Instrumentation Laboratory
  • Nihon Kohden Corporation
  • Roche Diagnostics (Schweiz) AG
  • Siemens Healthineers
  • Sysmex Corporation
  • Thermo Fisher Scientific, Inc.